Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Acute Respiratory Distress Syndrome
NCT01731795Phase 4Completed
- Sponsor
- Dr. Negrín University Hospital
- Start
- Mar 2013
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Dr. Negrín University Hospital. Primary endpoint: Ventilator-free days at 28 days. Started Mar 2013; status: completed.
02
Drugs
dexamethasone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT01731795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01731795.